234 related articles for article (PubMed ID: 8945770)
1. Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Marubayashi N; Sano M; Kanzaki K; Inaba K; Kawakita T
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2051-60. PubMed ID: 8945770
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 6-chloro-3,4-dihydro-4-methyl-2H-1,4-benzoxazine-8-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Sakamori M; Kawakita T
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):756-64. PubMed ID: 8681408
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of 2,3-dihydrobenzofuran-7-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Yasumoto M; Inaba K; Sakamori M; Takehara S; Kawakita T
Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):95-100. PubMed ID: 8124772
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacology of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives, a new class of potent serotonin-3 (5-HT3) receptor antagonists.
Kawakita T; Kuroita T; Yasumoto M; Sano M; Inaba K; Fukuda T; Tahara T
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):624-30. PubMed ID: 1611677
[TBL] [Abstract][Full Text] [Related]
5. New 5-HT3 (serotonin-3) receptor antagonists. V. Synthesis and structure-activity relationships of pyrrolo[2,1-c][1,4]benzoxazine-6-carboxamides.
Kato M; Nishino S; Ito K; Yamakuni H; Takasugi H
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1358-63. PubMed ID: 7553981
[TBL] [Abstract][Full Text] [Related]
6. 5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
Hayashi H; Miwa Y; Ichikawa S; Yoda N; Miki I; Ishii A; Kono M; Yasuzawa T; Suzuki F
J Med Chem; 1993 Mar; 36(5):617-26. PubMed ID: 8496941
[TBL] [Abstract][Full Text] [Related]
7. Development of potent serotonin-3 (5-HT3) receptor antagonists. I. Structure-activity relationships of 2-alkoxy-4-amino-5-chlorobenzamide derivatives.
Harada H; Morie T; Hirokawa Y; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1364-78. PubMed ID: 7553982
[TBL] [Abstract][Full Text] [Related]
8. Development of potent serotonin-3 (5-HT3) receptor antagonists. II. Structrue-activity relationships of N-(1-benzyl-4-methylhexahydro-1H-1,4- diazepin-6-yl)carboxamides.
Harada H; Morie T; Hirokawa Y; Terauchi H; Fujiwara I; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1912-30. PubMed ID: 8575032
[TBL] [Abstract][Full Text] [Related]
9. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists.
Turconi M; Nicola M; Quintero MG; Maiocchi L; Micheletti R; Giraldo E; Donetti A
J Med Chem; 1990 Aug; 33(8):2101-8. PubMed ID: 1695682
[TBL] [Abstract][Full Text] [Related]
11. New 5-HT3 (serotonin-3) receptor antagonists. IV. Synthesis and structure-activity relationships of azabicycloalkaneacetamide derivatives.
Kato M; Ito K; Nishino S; Yamakuni H; Takasugi H
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1351-7. PubMed ID: 7553980
[TBL] [Abstract][Full Text] [Related]
12. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
14. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
Kishibayashi N; Miwa Y; Hayashi H; Ishii A; Ichikawa S; Nonaka H; Yokoyama T; Suzuki F
J Med Chem; 1993 Oct; 36(22):3286-92. PubMed ID: 8230119
[TBL] [Abstract][Full Text] [Related]
15. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
[TBL] [Abstract][Full Text] [Related]
16. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. Synthesis and structure-activity relationships of 9-methyl-2,3,4,9-tetrahydrothiopyrano[2,3-b]indol-4-one derivatives.
Suzuki T; Matsuhisa A; Miyata K; Yanagisawa I; Ohta M
Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):101-6. PubMed ID: 9023971
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
18. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
[TBL] [Abstract][Full Text] [Related]
19. Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.
Robertson DW; Lacefield WB; Bloomquist W; Pfeifer W; Simon RL; Cohen ML
J Med Chem; 1992 Jan; 35(2):310-9. PubMed ID: 1732548
[TBL] [Abstract][Full Text] [Related]
20. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
Orjales A; Mosquera R; Labeaga L; Rodes R
J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
